PCI Biotech: Employee share option scheme in connection with promotion of new CSO Oslo, 10 January 2025 - PCI Biotech (OSE: PCIB), today announced...
PCI Biotech: Employee share option scheme Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted...
PCI Biotech first half 2024 interim results Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024...
PCI Biotech: Invitation to first half interim 2024 results presentation Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a...
Minutes of Annual General Meeting 2024 Oslo, 24 May 2024. The Annual General Meeting in PCI Biotech Holding ASA took place today, 24 May 2024. All...
Disclosure of voting rights for Chair of the Board Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this...
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024 Oslo, Norway 3 May 2024 - The annual general meeting of PCI Biotech Holding ASA...
PCI Biotech Holding ASA - Annual Report 2023 Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the...
PCI Biotech second half 2023 interim results Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half...
PCI Biotech: Invitation to second half interim 2023 results presentation Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a...
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing Oslo, Norway, 13 October 2023 – PCI Biotech...
PCI Biotech: European patent for mRNA delivery with fimaNAc Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical...
PCI Biotech: Employee share option scheme Oslo, 4 September 2023 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has...
PCI Biotech: Write-down of share capital registered Oslo, Norway, 1 September 2023 – PCI Biotech Holding ASA (OSE: PCIB) Reference is made to...
PCI Biotech first half 2023 interim results Oslo (Norway), 31 August 2023 – PCI Biotech (OSE: PCIB), today announces its interim first half...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads